RGCC and adenocarcinoma: We have originally demonstrated a role for RGC-32 deregulation in colon adenocarcinoma, showing that the intensity of RGC-32 immunohistochemical staining corresponded to the increase in the TNM staging of the adenocarcinomas (77).